• Je něco špatně v tomto záznamu ?

Sex-based differences in cardiac ischaemic injury and protection: therapeutic implications

B. Ostadal, P. Ostadal,

. 2014 ; 171 (3) : 541-54.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc15008614
E-zdroje Online Plný text

NLK Free Medical Journals od 1968 do Před 1 rokem
PubMed Central od 1968 do 2020
Europe PubMed Central od 1968 do Před 1 rokem
Medline Complete (EBSCOhost) od 2002-01-01 do Před 1 rokem
Wiley Free Content od 1997 do Před 1 rokem

Ischaemic heart disease (IHD) is the most frequent cause of mortality among men and women. Many epidemiological studies have demonstrated that premenopausal women have a reduced risk for IHD compared with their male counterparts. The incidence of IHD in women increases after menopause, suggesting that IHD is related to declining oestrogen levels. Experimental observations have confirmed the results of epidemiological studies investigating sex-specific differences in cardiac tolerance to ischaemia. Female sex appears also to favourably influence cardiac remodelling after ischaemia/reperfusion injury. Furthermore, sex-related differences in ischaemic tolerance of the adult myocardium can be influenced by interventions during the early phases of ontogenetic development. Detailed mechanisms of these sex-related differences remain unknown; however, they involve the genomic and non-genomic effects of sex steroid hormones, particularly the oestrogens, which have been the most extensively studied. Although the protective effects of oestrogen have many potential therapeutic implications, clinical trials have shown that oestrogen replacement in postmenopausal women may actually increase the incidence of IHD. The results of these trials have illustrated the complexity underlying the mechanisms involved in sex-related differences in cardiac tolerance to ischaemia. Sex-related differences in cardiac sensitivity to ischaemia/reperfusion injury may also influence therapeutic strategies in women with acute coronary syndrome. Women undergo coronary intervention less frequently and a lower proportion of women receive evidence-based therapy compared with men. Although our understanding of this important topic has increased in recent years, there is an urgent need for intensive experimental and clinical research to develop female-specific therapeutic strategies. Only then we will be able to offer patients better evidence-based treatment, a better quality of life and lower mortality.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008614
003      
CZ-PrNML
005      
20150313102044.0
007      
ta
008      
150306s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bph.12270 $2 doi
035    __
$a (PubMed)23750471
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Ostadal, B $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
245    10
$a Sex-based differences in cardiac ischaemic injury and protection: therapeutic implications / $c B. Ostadal, P. Ostadal,
520    9_
$a Ischaemic heart disease (IHD) is the most frequent cause of mortality among men and women. Many epidemiological studies have demonstrated that premenopausal women have a reduced risk for IHD compared with their male counterparts. The incidence of IHD in women increases after menopause, suggesting that IHD is related to declining oestrogen levels. Experimental observations have confirmed the results of epidemiological studies investigating sex-specific differences in cardiac tolerance to ischaemia. Female sex appears also to favourably influence cardiac remodelling after ischaemia/reperfusion injury. Furthermore, sex-related differences in ischaemic tolerance of the adult myocardium can be influenced by interventions during the early phases of ontogenetic development. Detailed mechanisms of these sex-related differences remain unknown; however, they involve the genomic and non-genomic effects of sex steroid hormones, particularly the oestrogens, which have been the most extensively studied. Although the protective effects of oestrogen have many potential therapeutic implications, clinical trials have shown that oestrogen replacement in postmenopausal women may actually increase the incidence of IHD. The results of these trials have illustrated the complexity underlying the mechanisms involved in sex-related differences in cardiac tolerance to ischaemia. Sex-related differences in cardiac sensitivity to ischaemia/reperfusion injury may also influence therapeutic strategies in women with acute coronary syndrome. Women undergo coronary intervention less frequently and a lower proportion of women receive evidence-based therapy compared with men. Although our understanding of this important topic has increased in recent years, there is an urgent need for intensive experimental and clinical research to develop female-specific therapeutic strategies. Only then we will be able to offer patients better evidence-based treatment, a better quality of life and lower mortality.
650    _2
$a akutní koronární syndrom $x farmakoterapie $x metabolismus $x patofyziologie $7 D054058
650    _2
$a androgeny $x metabolismus $7 D000728
650    _2
$a zvířata $7 D000818
650    _2
$a kardiovaskulární látky $x terapeutické užití $7 D002317
650    _2
$a náchylnost k nemoci $7 D004198
650    _2
$a estrogeny $x metabolismus $7 D004967
650    12
$a medicína založená na důkazech $7 D019317
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdce $x účinky léků $x patofyziologie $7 D006321
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ischemická choroba srdeční $x farmakoterapie $x metabolismus $x patofyziologie $7 D017202
650    _2
$a reperfuzní poškození myokardu $x prevence a kontrola $7 D015428
650    _2
$a myokard $x metabolismus $7 D009206
650    _2
$a pohlavní dimorfismus $7 D012727
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Ostadal, P
773    0_
$w MED00009383 $t British journal of pharmacology $x 1476-5381 $g Roč. 171, č. 3 (2014), s. 541-54
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23750471 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150313102323 $b ABA008
999    __
$a ok $b bmc $g 1065887 $s 891414
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 171 $c 3 $d 541-54 $i 1476-5381 $m British journal of pharmacology $n Br J Pharmacol $x MED00009383
LZP    __
$a Pubmed-20150306

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...